# Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery

> **NCT03965078** · — · COMPLETED · sponsor: **Portsmouth Hospitals NHS Trust** · enrollment: 123 (actual)

## Conditions studied

- Pseudophakic Cystoid Macular Oedema
- Epiretinal Membrane

## Interventions

- **DRUG:** topical (eye drop) anti-inflammatories

## Key facts

- **NCT ID:** NCT03965078
- **Lead sponsor:** Portsmouth Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2022-07-13
- **Final completion:** 2022-07-15
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2022-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03965078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03965078, "Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03965078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*